Clinical implications of pharmacogenomics for tardive dyskinesia

Pharmacogenomics J. 2004;4(2):77-87. doi: 10.1038/sj.tpj.6500233.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic / trends*
  • Dyskinesia, Drug-Induced / genetics*
  • Dyskinesia, Drug-Induced / metabolism
  • Humans
  • Pharmacogenetics / trends*